Showing results (851-860 of 1,006) with videos related to

Sort By:
Pageof 101
Ejhaem|July 18, 2022
A same-day assay predicts apoptotic response to combined BCL-2 and MCL-1 BH3-mimetic targeting in multiple myeloma cellsMartin Grundy, Firas Al-Kaisi, Joanna Cull, et al.
Ejhaem|July 18, 2022
Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D-VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant-eligible patients with newly diagnosed multiple myeloma, using propensity score matchingPhilippe Moreau, Cyrille Hulin, Sonja Zweegman, et al.
Ejhaem|July 18, 2022
Corrigendum
Ejhaem|July 18, 2022
Mantle cell lymphoma treatment options for elderly/unfit patients: A systematic reviewTahera Alnassfan, Megan J Cox-Pridmore, Azzam Taktak, et al.
Ejhaem|July 18, 2022
Is it safe and efficacious to remove central lines in pediatric bone marrow transplant patients with platelets less than 20,000/μl?Priya Marwah, Stalin Ramprakash, Sai Prasad T R, et al.
Ejhaem|July 18, 2022
Conditional relative survival among patients with chronic lymphocytic leukaemia: A population-based study in the NetherlandsLina van der Straten, Mark-David Levin, Otto Visser, et al.
Ejhaem|July 18, 2022
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio groupFrancesca Fazio, Luca Franceschini, Valeria Tomarchio, et al.
Ejhaem|July 18, 2022
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndromeYandong Shen, Luke Coyle, Ian Kerridge, et al.
Ejhaem|August 22, 2025
Disease Activity After Switching From Eculizumab to Ravulizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria: Real World Data From Denmark and FinlandAnders Rønneholt-Frederiksen, Dennis Lund Hansen, Vuokko Nummi, et al.
Ejhaem|August 8, 2022
Sickle cell disease patients with COVID-19 in Guadeloupe: Surprisingly favorable outcomesEmmanuelle Bernit, Marc Romana, Scylia Alexis-Fardini, et al.
Pageof 101